(Q46184012)

English

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

endometrial adenocarcinoma

1 reference

based on heuristic

inferred from title

Carsten Denkert

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

9

object named as

Manfred Dietel

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

4

object named as

Wilko Weichert

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

author name string

Silvia Darb-Esfahani

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Areeg Faggad

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Aurelia Noske

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Ann-Christin Buckendahl

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Berit Müller

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Jan Budczies

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Annika Röske

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

publication date

24 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

135

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

933-941

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

https://scigraph.springernature.com/pub.10.1007/s00432-008-0529-5

0 references

Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-008-0529-5

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS00432-008-0529-5

21 January 2018

Molecular and pathologic aspects of endometrial carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic parameters of endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PTEN function in normal and neoplastic growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the molecular target of rapamycin (mTOR).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of mTOR signaling pathway markers in prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic therapy in metastatic or recurrent endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mTOR and cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TOR signaling in growth and metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mTOR and cancer: insights into a complex relationship

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Akt/PKB Ser473 phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19107520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-008-0529-5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

release_elrzycywyzetrenspc534u2yuu

1 reference

https://api.fatcat.wiki/v0/release/elrzycywyzetrenspc534u2yuu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19107520

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46184012&oldid=2098550812"